Wu et al. found UCK2 (Uridine‐cytidine kinase 2) as a potential diagnostic and prognostic biomarker for lung cancer, and identified UCK2 highly expressed in stage IA lung cancer with AUC > 0.946. Here, UCK2 is linked to lung carcinoma.